Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Accessed Articles

COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide promotion: free to download

Volume: 20   Issue: 6
Pp: 410-416
Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419

C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors

Volume: 21   Issue: 1
Pp: 2-20
Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*
DOI: 10.2174/1568009620666201016121005

CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume: 20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study

Volume: 20   Issue: 11
Pp: 887-895
Martina Catalano, Giandomenico Roviello*, Raffaele Conca, Alberto D’Angelo, Valeria Emma Palmieri, Benedetta Panella, Roberto Petrioli, Anna Ianza, Stefania Nobili, Enrico Mini and Monica Ramello
DOI: 10.2174/1568009620999200918122426

Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma

Volume: 20   Issue: 11
Pp: 875-886
Yingyi Wang, Bao Jin, Na Zhou, Zhao Sun, Jiayi Li, Qiao Chen, Xiangan Wu, Yi Zhou, Yue Shi, Xin Lu, Xinting Sang, Yilei Mao, Shunda Du*, Wenze Wang* and Chunmei Bai*
DOI: 10.2174/1568009620999200918121456

Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis

Volume: 21   Issue: 1
Pp: 55-69
Sivakumar Murugesan, Jayakumar Murugesan, Seedevi Palaniappan , Sivasankar Palaniappan, Tamilselvi Murugan, Shahid S. Siddiqui and Sivakumar Loganathan*
DOI: 10.2174/1568009620666201009130008

MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy

Volume: 21   Issue: 2
Pp: 132-152
Chameli Ratan, Dalia Cicily K. D, Bhagyalakshmi Nair and Lekshmi. R. Nath*
DOI: 10.2174/1568009620666201116113334

Exosome as a Natural Gene Delivery Vector for Cancer Treatment

Volume: 20   Issue: 11
Pp: 821-830
Prasad Pofali, Adrita Mondal and Vaishali Londhe*
DOI: 10.2174/1568009620666200924154149

Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting

Volume: 21   Issue: 1
Pp: 70-79
Prakash Lingasamy, Anett-Hildegard Laarmann and Tambet Teesalu *
DOI: 10.2174/1568009620666201001112749

Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study

Volume: 21   Issue: 3
Pp: 203-212
Irina R. Gilyazova, Narasimha M. Beeraka, Elizaveta A. Klimentova, Kirill V. Bulygin, Vladimir N. Nikolenko, Adel A. Izmailov, Gulshat R. Gilyazova, Valentin N. Pavlov, Elsa K. Khusnutdinova, Siva G. Somasundaram, Cecil E. Kirkland and Gjumrakch Aliev*
DOI: 10.2174/1568009620666201120151226

Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL

Volume: 20   Issue: 10
Pp: 811-817
Sven Nilsson, Alexander Stein, Christian Rolfo, Anne L. Kranich, Julia Mann, Konstantinos Papadimitriou, Susann Theile, Stefanie Amberg and Carsten Bokemeyer*
DOI: 10.2174/1568009620666200628105727

Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy

Volume: 20   Issue: 11
Pp: 853-867
Han Gong, Dan Nie and Zhengyu Li*
DOI: 10.2174/1568009620999200816130218

Strategic Combination Therapies for Ovarian Cancer

Volume: 20   Issue: 8
Pp: 573-585
Xinran Li, Angel S.N. Ng, Victor C.Y. Mak, Karen K.L. Chan, Annie N.Y. Cheung and Lydia W.T. Cheung*
DOI: 10.2174/1568009620666200511084007

ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma

Volume: 21   Issue: 1
Pp: 80-89
Jingjing Wu, Zhengmei He, Yaning Zhu, Chao Jiang, Yuan Deng and Bin Wei*
DOI: 10.2174/1568009620666200915090703

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Volume: 21   Issue: 2
Pp: 117-131
Wenjun Wang, Ling Bai, Dongsheng Xu, Wei Li and Jiuwei Cui*
DOI: 10.2174/1568009620666200504111914

Immune Checkpoint Inhibitors in AML-A New Frontier

Volume: 20   Issue: 7
Pp: 545-557
Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo and Joshua F. Zeidner*
DOI: 10.2174/1568009620666200421081455

Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling

Volume: 20   Issue: 11
Pp: 868-874
Zhi Li, Wen-Qi Gao, Peng Wang, Tian-Qi Wang, Wen-Chao Xu, Xin-Yu Zhu and Hui Liu*
DOI: 10.2174/1568009620999200730184514